openPR Logo
Press release

Incredible Growth of +22.1% CAGR for Nanopharmaceuticals Market is Thriving Worldwide with Top Players Like Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited, Novavax, Inc., Stryker Corpor

03-02-2019 09:32 AM CET | Health & Medicine

Press release from: Coherent Market Insights,Inc

Nanopharmaceuticals

Nanopharmaceuticals

Key players in the market are focused on research and development of nanopharmaceuticals in order to develop novel products to address the critical unmet needs of patients. According to the P&T Community Journal, December 2017, DTXSPL8783, dendrimer for cancer treatment is being investigated, which is in clinical trials of phase 1 study, for patients with advanced cancer.

Download PDF Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/2485

Similarly, Vivagel developed by Starpharma, is in phase 3 clinical trials, for bacterial vaginosis. Vivagel sale is approved in Europe and Australia. Moreover, increase in incidences of cardiovascular diseases and other diseases, is expected to boost the market growth. According to World Health Organization, factsheet 2017, around 17.9 million deaths were recorded due to cardiovascular diseases in 2016. Cardiovascular diseases was recorded as the leading cause of death, globally.

Key players in the market are focused on adopting strategies such as mergers and acquisitions to enhance its product portfolio. For instance, in December 2018, Novartis acquired Endocyte, Inc., involved in developing Radioligland and other therapies for treatment of cancer. This acquisition helped Novartis to strengthen its position in cancer treatment and expand its products offering to align better healthcare.

Increasing prevalence of cardiovascular diseases, cancer, and infectious diseases are major factors driving nanopharmaceuticals market growth. The World Health Organization, factsheet September 2018, estimated around 10 million cases of tuberculosis and around 1.6 million deaths from the disease in 2017. Moreover, advantages of nanopharmaceuticals over macroscopic level medicines is expected to boost the market growth. Nanopharmaceuticals can pass the blood brain barrier and can access the remote areas of brain as well as low solubility of the compound can be developed for enhancing its characteristics.

Request a Sample Copy @ https://www.coherentmarketinsights.com/insight/request-sample/2485

Detailed Segmentation:

Global Nanopharmaceuticals Market, By Carrier:
Liposomes
Polymer
Nanocrystals
Inorganic
Protein
Others
Global Nanopharmaceuticals Market, By Application:
Oncology
Neurology
Anti-inflammatory
Anti-infective
Cardiovascular
Others
Global Nanopharmaceuticals Market, By Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Incredible Growth of +22.1% CAGR for Nanopharmaceuticals Market is Thriving Worldwide with Top Players Like Novartis AG, Pfizer, Inc., Hoffmann-La Roche AG, Sanofi S.A, Shire Plc., and Teva Pharmaceuticals Industries Limited, Novavax, Inc., Stryker Corpor here

News-ID: 1627794 • Views:

More Releases from Coherent Market Insights,Inc

Childhood Absence Epilepsy Treatment Market Growing at a CAGR of 5.4% by 2026, Focusing on top key players Pfizer, Inc., GlaxoSmithKline Plc, Insys Therapeutics, Inc., AbbVie, Inc., and Teva Pharmaceutical Industries Ltd
Childhood Absence Epilepsy Treatment Market Growing at a CAGR of 5.4% by 2026, F …
According to various studies published by the National Center for Biotechnology Information and recent recommendation by the National Institute for Health and Care Excellence (NICE), 2018, Ethosuximide should be considered as a first choice of treatment, followed by Valproate and Lamotrigine. Moreover, various manufacturers such as Insys Therapeutics (Cannabidiol) and Cavion, Inc. (CX-8998) have drugs in phase II stage in clinical trials and these therapies are expected to be launched
Pneumococcal Vaccines Market is anticipated to grow at a CAGR of 7.5% by 2026: Top key players Pfizer, Inc., Merck & Co. Inc., and GlaxoSmithKline plc
Pneumococcal Vaccines Market is anticipated to grow at a CAGR of 7.5% by 2026: T …
Healthcare facilities are looking forward to expand their facilities with advanced technologies to create innovative and cost-effective solutions to address barriers to universal vaccination For instance, in April 2016, Glaxo Smith Kline (GSK) and Vodafone collaborated to provide smartphones with an app to various healthcare facilities in northern Mozambique, Africa for a period of one year. The program received funds from GAVI and United States Agency for International Development (USAID) under
Ureteral Stents Market Global Outlook 2018-2026 | Leading Vendors Applied Medical, Allium Medical, Bard Medical, B.Braun, Boston Scientific, Cook Medical, Coloplast, Conmed Corporation, Optimed, Olympus America, Pnn Medical A/S, Taewoong Med
Ureteral Stents Market Global Outlook 2018-2026 | Leading Vendors Applied Medica …
New designs such as a helically-cut ureteral stent is aimed to stretch and conform the ureter. Drug-eluting stents with an antimicrobial property are designed to reduce bacterial adherence to ureteral stents. Furthermore, bioabsorbable stents are designed to reduce infection and prevent the forgotten stent syndrome. In June 2018, HydrUStent, a startup based at the University of Minho in Portugal, announced its research on developing a ureteral stent made from a
Newborn Screening Market Studied by Focusing on Major Companies: Agilent Technologies, AB SCIEX, Bio-Rad Laboratories, Covidien PLC, GE Life Sciences, Masimo Corporation, Natus Medical Inc., PerkinElmer
Newborn Screening Market Studied by Focusing on Major Companies: Agilent Technol …
Newborn screening tests look for developmental, metabolic, and genetic disorders in infants. It allows steps to be taken before development of symptoms. Although, majority of these illnesses are very rare, they can be treated with early diagnosis. Newborn screening includes over 30 conditions and illnesses. Increasing awareness among parents for disease screening is a major factor driving newborn screening market growth. Furthermore, various government and non-government organizations are actively focused

All 5 Releases


More Releases for Nanopharmaceuticals

Evolving Market Trends In The Nanopharmaceuticals Industry: Strategic Partnershi …
The Nanopharmaceuticals Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Nanopharmaceuticals Market Size During the Forecast Period? The nanopharmaceuticals market size will grow from $95.21 billion in 2024 to $112.49 billion in 2025, at a CAGR of 18.2%. The growth is driven
Prominent Nanopharmaceuticals Market Trend for 2025: Strategic Partnerships Driv …
"What Are the Projected Growth and Market Size Trends for the Nanopharmaceuticals Market? In recent times, the nanopharmaceuticals market has seen quick expansion. Its value is projected to rise from $95.21 billion in 2024 to $112.49 billion in 2025, with a compound annual growth rate (CAGR) of 18.2%. This rapid development in the historical period is linked to the need for efficient therapy, growing recognition of nanopharmaceuticals, the demand for specialized
Nanopharmaceuticals Market Exhibits a Stunning Growth | Merck, Pfizer, Novartis
Latest Study on Industrial Growth of Global Nanopharmaceuticals Market 2024-2030. A detailed study accumulated to offer the Latest insights about acute features of the Nanopharmaceuticals market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments
Nanopharmaceuticals Market Set for More Growth: Merck, Pfizer, Novartis
Latest Study on Industrial Growth of Global Nanopharmaceuticals Market 2023-2029. A detailed study accumulated to offer the Latest insights about acute features of the Nanopharmaceuticals market. The report contains different market predictions related to revenue size, production, CAGR, Consumption, gross margin, price, and other substantial factors. While emphasizing the key driving and restraining forces for this market, the report also offers a complete study of the future trends and developments
Nanopharmaceuticals Market Share, Sales Channels and Overview Till 2028
Nanopharmaceuticals is an upcoming part of nanomedicine, which includes discovery/development and delivery of drugs using nanobiotechnology. It also includes the use of nanoparticles as therapeutic agents in various medical fields such as oncology, neurology, infectious diseases and others. nanopharmaceuticals are known to have different chemical, physical and biological properties as compared to its lager counterparts. These compounds have a larger surface area coupled with nano scale properties, which can be
Nanopharmaceuticals Market – Detailed Analysis of Potential Growth and Forecas …
Nanopharmaceuticals Market Report 2021 added recently by Coherent Market Insights, evaluates the industry in terms of market size, market share, revenue estimation, and geographical outlook. The study also delivers a precise summary that illustrates the competitive milieu, growth opportunities and application landscape of the Nanopharmaceuticals depending on the industry's financial and non-financial impact. The complete range of information related to the Global Nanopharmaceuticals Market is obtained through various sources and